Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreYour selected location is
Middle East / Africa
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Flow cytometric analysis of LGR5 expression on human LGR5-transfected cells. LS 174T colorectal adenocarcinoma cells transfected with human LGR5 (cells from Dr. Hans Clevers, Hubrecht Institute, Left Panel) and parental LS 174T cells, which express low levels of endogenous LGR5 (ATCC CL-188, Right Panel) were harvested using Accutase™ Cell Detachment Solution (Cat. No. 561527). The cells were stained with either Alexa Fluor® 647 Rat IgG2b, κ Isotype Control (Cat. No. 557691; dashed line histogram) or Alexa Fluor® 647 Rat anti-Human Lgr5 (Central LRR) antibody (Cat. No. 562912; solid line histogram) at matched concentrations. The fluorescence histograms were derived from gated events based on the light scattering characteristics of viable LS 174T cells. Flow cytometry was performed on a BD FACSCanto™ II Flow Cytometry System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5) is a seven transmembrane-domain receptor that is a target gene for Wnt and marks stem cells in the small intestine, colon, stomach, and hair follicle. Lgr5 was initially identified as a potential stem cell marker due to restricted expression of Lgr5 in the intestinal crypt and labeling of rapidly cycling cells of the colon and intestine. Using both lineage tracing and organoid culture experiments, Lgr5 positive cells are capable of generating all types of the small intestine epithelium hence indicating that Lgr5 marks stem cells of the small intestine and colon. R-spondin growth factors, which are secreted agonists of the Wnt pathway, bind Lgr5. The binding of R-spondins to Lgr5 leads to recruitment of the Frizzled/LRP Wnt receptor complex, which binds to Wnt ligands and leads to downstream Wnt signaling. Lgr5 is up-regulated in colon and ovarian cancers and has been implicated in promotion of tumor growth and metastasis.
The 4D11F8 monoclonal antibody recognizes an epitope in the center of the leucine-rich repeat (LRR) region of Human Lgr5.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.